ID: ALA2408493

Max Phase: Preclinical

Molecular Formula: C16H16N2

Molecular Weight: 236.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc(CN2CCN=C2c2ccccc2)cc1

Standard InChI:  InChI=1S/C16H16N2/c1-3-7-14(8-4-1)13-18-12-11-17-16(18)15-9-5-2-6-10-15/h1-10H,11-13H2

Standard InChI Key:  XECZPMLUVPEPKQ-UHFFFAOYSA-N

Associated Targets(non-human)

Tetranychus urticae 2600 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 236.32Molecular Weight (Monoisotopic): 236.1313AlogP: 2.95#Rotatable Bonds: 3
Polar Surface Area: 15.60Molecular Species: BASEHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.65CX LogP: 3.21CX LogD: 1.97
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.80Np Likeness Score: -0.85

References

1. KAGABU S, SAKOU M, IWAYA K, KIRIYAMA K.  (2001)  Synthesis and Acaricidal Activity of 1-Arylmethyl-2-arylimidazolidines,  26  (4): [10.1584/jpestics.26.393]
2. Azevedo LM, Lansdell TA, Ludwig JR, Mosey RA, Woloch DK, Cogan DP, Patten GP, Kuszpit MR, Fisk JS, Tepe JJ..  (2013)  Inhibition of the human proteasome by imidazoline scaffolds.,  56  (14): [PMID:23789888] [10.1021/jm400235r]

Source